KW 3196
Latest Information Update: 30 Mar 1995
At a glance
- Originator Kyowa Hakko
- Class Heart failure therapies; Ischaemic heart disorder therapies; Organic nitrates; Vasodilators
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Angina pectoris; Heart failure
Most Recent Events
- 30 Mar 1995 Discontinued-Preclinical for Angina pectoris in Japan (Unknown route)
- 30 Mar 1995 Discontinued-Preclinical for Heart failure in Japan (Unknown route)